Eric Chadwick Email & Phone Number

Seattle, Washington, Us

Shape Therapeutics (Shape Tx) is a development-stage biotechnology company establishing itself as the leader in next-generation gene therapy. Our novel technology platforms enable direct in vivo targeting/modification of RNA by leveraging ADARs (Adenosine Deaminase Acting on RNA), suppressor tRNAs, gene replacement therapy using novel promoter and enhancer elements, and payload delivery with novel adeno-associated viral vectors (AAVs).My primary role is leading a team of talented scientists and research associates in establishing preclinical in vivo studies to advance our technology platforms and to evaluate lead candidates in the relevant disease models.

Seattle, Washington, Us

Seattle, Wa, Us

Seattle, Washington, Us

Discovery Biology Group focused on oncology and immuno-oncology disease target discovery and validation using both in vitro and in vivo model systems

Seal Beach , Ca, Us

Worked in the Research Immunology Group developing novel methods of activating the immune system to treat cancer. This included working with and developing in vivo tumor models and optimizing anti-tumor immunization strategies as part of efforts to develop new products, and to support the evaluation of the research platform.

Seattle, Wa, Us

Performed experiments to refine strategies of pretargeted radioimmunotherapy for the treatment of leukemia and lymphomas.

Seattle, Wa, Us

Participated in the Target Discovery platform, screening viral virulence factors in order to identify cellular targets which can be targeted to modulate the immune system with therapeutics for autoimmune and inflammatory diseases.

Seal Beach , Ca, Us

As a member of the Immune Monitoring Group, I had the opportunity to study various time points of samples and cellular product from clinical trials of patients undergoing treatment with Provenge, the first FDA-approved autologous cellular immunotherapy. These studies contributed to efforts in order to achieve more in-depth product characterization, establish a mechanism of action, and to collect data to guide future clinical programs at Dendreon.

Seattle, Washington, Us